Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

Utilizing buprenorphine-naloxone to treat illicit and prescription-opioid dependence.

Mauger S, Fraser R, Gill K.

Neuropsychiatr Dis Treat. 2014 Apr 7;10:587-98. doi: 10.2147/NDT.S39692. eCollection 2014. Review.

PMID:
24741316
[PubMed]
Free PMC Article
2.

Implementing community-based provider participation in research: an empirical study.

Teal R, Bergmire DM, Johnston M, Weiner BJ.

Implement Sci. 2012 May 8;7:41. doi: 10.1186/1748-5908-7-41.

PMID:
22568935
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Physicians in the substance abuse treatment workforce: understanding their employment within publicly funded treatment organizations.

Knudsen HK, Oser CB, Abraham AJ, Roman PM.

J Subst Abuse Treat. 2012 Sep;43(2):152-60. doi: 10.1016/j.jsat.2011.12.003. Epub 2012 Feb 1.

PMID:
22301083
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Update on the clinical use of buprenorphine: in opioid-related disorders.

Ducharme S, Fraser R, Gill K.

Can Fam Physician. 2012 Jan;58(1):37-41. Review.

PMID:
22267618
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Perceptions of the state policy environment and adoption of medications in the treatment of substance use disorders.

Knudsen HK, Abraham AJ.

Psychiatr Serv. 2012 Jan;63(1):19-25. doi: 10.1176/appi.ps.201100034.

PMID:
22227755
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Influence of religiosity on 12-step participation and treatment response among substance-dependent adolescents.

Kelly JF, Pagano ME, Stout RL, Johnson SM.

J Stud Alcohol Drugs. 2011 Nov;72(6):1000-11.

PMID:
22051214
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Timing of buprenorphine adoption by privately funded substance abuse treatment programs: the role of institutional and resource-based interorganizational linkages.

Savage SA, Abraham AJ, Knudsen HK, Rothrauff TC, Roman PM.

J Subst Abuse Treat. 2012 Jan;42(1):16-24. doi: 10.1016/j.jsat.2011.06.009. Epub 2011 Aug 9.

PMID:
21831565
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment.

Rieckmann TR, Kovas AE, McFarland BH, Abraham AJ.

J Subst Abuse Treat. 2011 Dec;41(4):374-85. doi: 10.1016/j.jsat.2011.05.005. Epub 2011 Aug 6.

PMID:
21821379
[PubMed - indexed for MEDLINE]
Free PMC Article
9.
10.

Availability of nicotine replacement therapy in substance use disorder treatment: longitudinal patterns of adoption, sustainability, and discontinuation.

Knudsen HK, Studts JL.

Drug Alcohol Depend. 2011 Nov 1;118(2-3):244-50. doi: 10.1016/j.drugalcdep.2011.03.028. Epub 2011 Apr 29.

PMID:
21531090
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation.

Roman PM, Abraham AJ, Knudsen HK.

Addict Behav. 2011 Jun;36(6):584-9. doi: 10.1016/j.addbeh.2011.01.032. Epub 2011 Jan 27.

PMID:
21377275
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Adoption and implementation of medications in addiction treatment programs.

Knudsen HK, Abraham AJ, Roman PM.

J Addict Med. 2011 Mar;5(1):21-7. doi: 10.1097/ADM.0b013e3181d41ddb.

PMID:
21359109
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Adoption of medications in substance abuse treatment: priorities and strategies of single state authorities.

Rieckmann T, Kovas AE, Rutkowski BA.

J Psychoactive Drugs. 2010 Sep;Suppl 6:227-38.

PMID:
21138199
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal.

Paronis CA, Bergman J.

J Pharmacol Exp Ther. 2011 Feb;336(2):488-95. doi: 10.1124/jpet.110.173823. Epub 2010 Nov 4.

PMID:
21051498
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

From research to the real world: buprenorphine in the decade of the Clinical Trials Network.

Ling W, Jacobs P, Hillhouse M, Hasson A, Thomas C, Freese T, Sparenborg S, McCarty D, Weiss R, Saxon A, Cohen A, Straus M, Brigham G, Liu D, McLaughlin P, Tai B.

J Subst Abuse Treat. 2010 Jun;38 Suppl 1:S53-60. doi: 10.1016/j.jsat.2010.01.009.

PMID:
20307796
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

A longitudinal study of organizational formation, innovation adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network.

Roman PM, Abraham AJ, Rothrauff TC, Knudsen HK.

J Subst Abuse Treat. 2010 Jun;38 Suppl 1:S44-52. doi: 10.1016/j.jsat.2009.12.008.

PMID:
20307795
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Partnerships and pathways of dissemination: the National Institute on Drug Abuse-Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network.

Martino S, Brigham GS, Higgins C, Gallon S, Freese TE, Albright LM, Hulsey EG, Krom L, Storti SA, Perl H, Nugent CD, Pintello D, Condon TP.

J Subst Abuse Treat. 2010 Jun;38 Suppl 1:S31-43. doi: 10.1016/j.jsat.2009.12.013.

PMID:
20307793
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The adoption of alcohol pharmacotherapies in the Clinical Trials Network: the influence of research network participation.

Abraham AJ, Knudsen HK, Rothrauff TC, Roman PM.

J Subst Abuse Treat. 2010 Apr;38(3):275-83. doi: 10.1016/j.jsat.2010.01.003. Epub 2010 Feb 1.

PMID:
20117908
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk